Novo Nordisk (Ozempic)

12771.503 - 12792.833 Ben Gilbert

Shareholders in pharma companies feel like they're actually not making that much money. If you look at the whole industry, their return on invested capital is maybe slightly better, but pretty much on par with other industries. So square that circle. It's pretty weird. All right, bear bowl, David. And we can be reasonably quick in this since I think we've hit a lot of these points along the way.